Published in Blood Weekly, April 29th, 2010
"The Ki-67 antibody is used to determine the proliferative rate of tumors. This antibody is clinically important for diagnosis and treatment decisions because the amount of staining is proportional to the grade of a tumor. Higher-grade tumors are going to be treated differently and more aggressively by the clinicians as compared with their lower-grade counterparts. The problem with using the stain alone is that there are often normal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.